ArticleFrontiers in oncology2025

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Holger N Lode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.